Literature DB >> 17890710

Interventional procedures for atherothrombosis: pathology of retrieved material.

Annalisa Angelini1, Mila Della Barbera, Gaetano Thiene.   

Abstract

Mesh：

Year:  2007        PMID： 17890710      PMCID： PMC2000959          DOI： 10.1136/hrt.2004.057430

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  19 in total

1.  Relation of CD39 to plaque instability and thrombus formation in directional atherectomy specimens from patients with stable and unstable angina pectoris.

Authors:  Kinta Hatakeyama; Hiroyuki Hao; Takuroh Imamura; Tetsunori Ishikawa; Yoshisato Shibata; Yoshihiro Fujimura; Tanenao Eto; Yujiro Asada
Journal:  Am J Cardiol       Date:  2005-03-01       Impact factor: 2.778

2.  Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention.

Authors:  Saskia Z H Rittersma; Allard C van der Wal; Karel T Koch; Jan J Piek; José P S Henriques; Karla J Mulder; Johanna P H M Ploegmakers; Martin Meesterman; Robbert J de Winter
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

3.  Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke.

Authors:  Luigi Giusto Spagnoli; Alessandro Mauriello; Giuseppe Sangiorgi; Stefano Fratoni; Elena Bonanno; Robert S Schwartz; David G Piepgras; Raimondo Pistolese; Arnaldo Ippoliti; David R Holmes
Journal:  JAMA       Date:  2004-10-20       Impact factor: 56.272

4.  Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.

Authors:  Gregg W Stone; John Webb; David A Cox; Bruce R Brodie; Mansoor Qureshi; Anna Kalynych; Mark Turco; Heinz P Schultheiss; Daniel Dulas; Barry D Rutherford; David Antoniucci; Mitchell W Krucoff; Raymond J Gibbons; Denise Jones; Alexandra J Lansky; Roxana Mehran
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

Review 5.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-14       Impact factor: 29.690

6.  Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis.

Authors:  Dirk Skowasch; Alexander Jabs; René Andrié; Sabine Dinkelbach; Berndt Lüderitz; Gerhard Bauriedel
Journal:  Cardiovasc Res       Date:  2003-12-01       Impact factor: 10.787

7.  Distal protection with a filter device during coronary stenting in patients with stable and unstable angina.

Authors:  Annalisa Angelini; Paolo Rubartelli; Flavio Mistrorigo; Mila Della Barbera; Francesco Abbadessa; Massimo Vischi; Gaetano Thiene; Sergio Chierchia
Journal:  Circulation       Date:  2004-07-26       Impact factor: 29.690

8.  Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome.

Authors:  Jun-ichi Kotani; Shinsuke Nanto; Gary S Mintz; Masafumi Kitakaze; Tomoki Ohara; Takakazu Morozumi; Seiki Nagata; Masatsugu Hori
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling.

Authors:  Paul Schoenhagen; D Geoffrey Vince; Khaled M Ziada; Samir R Kapadia; Michael A Lauer; Timothy D Crowe; Steven E Nissen; E Murat Tuzcu
Journal:  Am J Cardiol       Date:  2002-06-15       Impact factor: 2.778
View more
  1 in total

1.  The impact of anti-inflammatory cytokines provoked by CD163 positive macrophages on ventricular functional recovery after myocardial infarction.

Authors:  Takao Sato; Tomoki Kameyama; Takahisa Noto; Teruo Nakadate; Hiroshi Ueno; Kunihiro Yamada; Hiroshi Inoue
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.